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Abstract
Background: It is estimated that over 8 million people in the United Kingdom suffer from osteoarthritis. These
patients may require orthopaedic surgical intervention to help alleviate their clinical condition. Investigations
presented here was to test the hypothesis that total hip replacement (THR) and total knee replacement (TKR)
orthopaedic surgery result in changes to leukocyte and endothelial markers thus increasing inflammatory reactions
postoperatively.
Methods: During this ‘pilot study’, ten test subjects were all scheduled for THR or TKR elective surgery due to
osteoarthritis. Leukocyte concentrations were measured using an automated full blood count analyser. Leukocyte
CD11b (Mac-1) and CD62L cell surface expression, intracellular production of H2O2 and elastase were measured as
markers of leukocyte function. Von Willebrand factor (vWF) and soluble intercellular adhesion molecule-1 (sICAM-1)
were measured as markers of endothelial activation.
Results: The results obtained during this study demonstrate that THR and TKR orthopaedic surgery result in similar
changes of leukocyte and endothelial markers, suggestive of increased inflammatory reactions postoperatively.
Specifically, THR and TKR surgery resulted in a leukocytosis, this being demonstrated by an increase in the total
leukocyte concentration following surgery. Evidence of leukocyte activation was demonstrated by a decrease in
CD62L expression and an increase in CD11b expression by neutrophils and monocytes respectively. An increase in
the intracellular H2O2 production by neutrophils and monocytes and in the leukocyte elastase concentrations was
also evident of leukocyte activation following orthopaedic surgery. With respect to endothelial activation, increases
in vWF and sICAM-1 concentrations were demonstrated following surgery.
Conclusion: In general it appeared that most of the leukocyte and endothelial markers measured during these
studies peaked between days 1-3 postoperatively. It is proposed that by allowing orthopaedic surgeons access to
alternative laboratory markers such as CD11b, H2O2 and elastase, CD62L, vWF and sICAM-1, an accurate assessment
of the extent of inflammation due to surgery per se could be made. Ultimately, the leukocyte and endothelial
markers assessed during this investigation may have a role in monitoring potential infectious complications that
can occur during the postoperative period.
Background
Involvement of the phagocytic leukocytes during an
inflammatory response can be appreciated to be an impor-
tant aspect of the innate (natural) immune response. Dur-
ing surgical procedures changes to the concentration of
these circulating cell types (neutrophils and monocytes)
can occur. A study by Wiik (2001) has demonstrated that
abdominal surgery causes an increase in neutrophil and
monocyte counts along with lymphocytopenia [1].
Høgevold et al (1999) have demonstrated that changes in
leukocyte subpopulations occur in patients undergoing
total hip replacement surgery. Specifically, the study
involved twelve patients and found a leukocytosis, mono-
cytosis, lymphocytopenia and granulocytosis after surgery
[2]. Spark & Scott (2001) have also provided evidence to
suggest that neutrophils play a critical early step in the
development of the ischaemia-reperfusion syndrome, the
systemic inflammatory response syndrome (SIRS) and sep-
sis following surgery [3].
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endothelial involvement as part of the post-operative
period has not yet been extensively researched, particu-
larly studies comparing a range of biological markers.
Measurement of these parameters following lower limb
orthopaedic surgery may therefore provide a useful tool
as indicative markers following lower limb surgery.
The main aim of this pilot clinical study was to assess
the effects of total hip replacement (THR) and total
knee replacement (TKR) orthopaedic surgery on a range
of leukocyte and endothelial markers. TKR involves
using a tourniquet, creating a bloodless field for the sur-
geons to perform their work. During this time it can be
appreciated that ischaemia-reperfusion injury may be
incurred. Ischaemia is the reduction of blood supply to
a part of the body and reperfusion occurs when blood
flow is re-established. Ischaemia causes tissue injury, but
it is during the period of reperfusion that extensive host
tissue damage is proposed to occur, and has thus been
termed ischaemia-reperfusion injury [4-10]. Ischaemia-
reperfusion injury occurs in diseases such as ischemic
heart disease, peripheral vascular disease and during sur-
gical procedures, which involve the application of a
tourniquet, such as upper limb (e.g. fasiectomy and car-
pal tunnel) and lower limb (e.g. knee arthroplasty and
TKR) orthopaedic surgery [6,11-13]. It can be appre-
ciated that during episodes of ischaemia-reperfusion
injury an inflammatory response ensues, which would
involve specific interactions between the phagocytic leu-
kocytes and the vascular endothelium. This research
investigation explored the role of leukocyte and
endothelial markers in a clinical setting. THR and TKR
surgery in general follow an uncomplicated course post-
operatively, and it can be appreciated that the complica-
tion that surgeons fear most post-operatively are
infections, as monitored by C-reactive protein (CRP)
levels. However, little evidence is available to demon-
strate the effects of orthopaedic surgery on other inflam-
matory markers, such as those of leukocytes and
endothelial cells.
Therefore the study was undertaken to test the
hypothesis that lower limb orthopaedic surgery results
in changes to leukocyte and endothelial markers indicat-
ing inflammatory reactions postoperatively.
It is anticipated that any changes in the measured
parameters may provide future direction with respect to
therapeutic intervention. For example, if THR and TKR
surgery results in prolonged leukocyte and endothelial
activation, anti-adhesion molecules or free radical oxy-
gen scavengers (e.g. anti-oxidants such as mannitol and
vitamin E) may help reduce leukocyte and endothelial
activation respectively, and thus reduce the inflamma-
tory course postoperatively, which may have an
important impact with regards to treatment strategies
following orthopaedic trauma.
Methods
Subject Volunteers
Ethical approval for this study was permitted from the
National Research Ethics Service (NRES). Ten volun-
teers scheduled for either elective THR or TKR surgery
were recruited after informed consent. The test subjects
were aged between 58 and 87 years old (mean age = 77
for both THR and TKR), and were all scheduled for
elective surgery due to osteoarthritis. 5 patients were
scheduled for THR (3 females and 2 males) and 5
patients for TKR (3 females and 2 males).
THR surgery
Prior to surgery an 18GA cannula (BD VenflonTM,
Sweden) was inserted into the arm at the ante-cubital
fossa. A venous blood sample was then collected preo-
peratively, which stood as a baseline measurement for
that particular patient. In theatre, patients were prepared
for THR surgery by undergoing general anaesthesia.
Blood samples were then collected from the arm by
means of the cannula following surgery at day 1, 3 and
5 post-operatively. No tourniquet was used during this
orthopaedic surgical procedure.
TKR surgery
Prior to surgery an 18GA cannula (BD VenflonTM,
Sweden) was inserted into the arm at the ante-cubital
fossa. A venous blood sample was then collected preo-
peratively, which stood as a baseline measurement for
that particular patient. In theatre, patients were prepared
for TKR by undergoing general anaesthesia. Prior to
commencing surgery the tourniquet was set around the
upper thigh and inflated to 315 ± 9.80 mmHg, to ensure
a bloodless field prior to surgery. The mean time of
ischaemia was 94 ± 7.47 minutes per TKR surgical pro-
cedure. Blood samples were then collected from the arm
by means of the cannula, upon the release of tourniquet
a t5a n d1 5m i n u t e sr e p e r f u s i o n ,d a y1 ,3a n d5p o s t -
operatively.
Preparation of cell suspensions
Purified neutrophils and mononuclear cell suspensions
were prepared by density gradient sedimentation on
ficoll hypaque solutions as described by Lennie et al,
(1987) [14]. Following isolation, cells were re-suspended
in phosphate buffered saline (PBS) supplemented with
di-potassium EDTA (1.5 mg/ml) to yield a final cell
count of 2 × 10
6 cells/ml. All chemicals were supplied
by Sigma-Aldrich, UK.
Measurement of leukocyte concentration
Following venepuncture total leukocyte counts were per-
formed using a Coulter® MicroDiff[18] blood analyser
(Beckman Coulter, UK).
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CD11b
The monoclonal antibodies used were mouse anti-
human CD62L (MCA1076F) and isotype-matched con-
t r o lI g G 2 b( M C A 6 9 1 F ) ,m o u s ea n t i - h u m a nC D 1 1 b
(MCA551F) and isotype-matched control IgG1
(MCA928F), and were purified immunoglobulin/fluores-
cein isothiocyanate (Ig/FITC) conjugates (AbD Serotec
Ltd., U.K.). Following isolation of leukocyte subpopula-
tions and adjustment of concentration (2 × 10
6 cells/
ml), 10 μl of the monoclonal antibody (0.1 mg/ml) was
added to 100 μl of the appropriate cell suspension.
These were incubated at room temperature for 30 min-
utes, prior to assay analysis using flow cytometry of
gated monocytes and neutrophils.
Measurement of intracellular H2O2 production
Cells were isolated and intracellular H2O2 production
was assessed by adaptation of a technique previously
described by Bass et al (1983) [15]. The assay was based
on the oxidation by H2O2 of non-fluorescent 2’,7 ’-
dichlorofluoroscin diacetate (DCFH-DA) to stable and
fluorescent dichlorofluorescein. H2O2 production was
assessed in cells using a fixed volume of 0.5 ml cell sus-
pension (2 × 10
6 cells/ml) mixed with 0.5 ml DCFH-DA
(20 μM) in PBS. Cells were incubated in the dark, at 37°
C for 30 minutes before immediate measurement using
flow cytometry of gated monocytes and neutrophils.
Measurement of plasma concentrations of leukocyte
elastase
Blood samples were collected into EDTA tubes and
were centrifuged at 1500 g for 10 minutes within 4
hours of blood collection. Plasma was removed and
stored at -30°C. Quantification of human leukocyte elas-
tase in subject plasma was carried out by ELISA using
commercial kits provided by IBL (Hamburg, Germany)
employing the method as initially described by Brower
& Harpel (1983)[16].
Measurement of plasma concentration of vWF and
sICAM-1
Blood samples were collected into tri-sodium citrate
tubes and were centrifuged at 1500 g for 10 minutes
within 4 hours of blood collection. Plasma was removed
and stored at -30°C. Quantification of vWF and sICAM-
1 was subsequently measured by a two step enzyme
immunoassay sandwich method. Measurement of the
vWF parameter was performed using a Mini-Vidas auto-
mated immunoassay system that uses ELFA (Enzyme-
Linked Fluorescent Assay) technology. The Mini-Vidas
system and immunoassay kits were supplied from Bio-
merieux, UK. sICAM-1 was measured using commercial
kits available from R&D Systems Europe (U.K).
Statistical analysis
During this study, all results were presented as mean ±
standard deviation (SD). Where data were normally
distributed, repeated measures one-way analysis of var-
iance (ANOVA) between samples test was employed
adopting a 5% level of significance. Post hoc testing was
conducted using the Tukey test for pairwise compari-
sons between means. Data that did not comply with
normality were analysed using the Friedman test. Where
the Friedman test resulted in statistical significance, sub-
sequent tests were performed using the Wilcoxon test.
Statistical significance was accepted when p ≤ 0.05.
Although no power calculations were performed, it is
acknowledged that a limiting factor of this study was
the relatively small number of patients recruited (n =
10). In order to fully appreciate the effects of surgery on
the parameters measured more patients could have been
recruited. This in-turn would have been beneficial to
some of the statistical trends that were observed, that
otherwise may have resulted in significant differences. It
would also have been interesting to have followed up
the patients with regards to measurement of their biolo-
gical markers at review clinic’s, this could have indicated
any continued inflammatory reactions post surgery,
which may have had an impact in supporting surgeons
with their management strategies of patients during the
post-operative period.
Results
Effect of THR and TKR surgery on leukocyte parameters
Leukocyte Count
Following THR and TKR surgery significant changes
were seen in the total leukocyte concentrations (p =
<0.05) (Figure 1). With regards to THR, the leukocyte
concentration increased from baseline (8.24 ± 2.11) to
day 1 postoperative (11.48 ± 2.17). The leukocyte con-
centration gradually decreased back towards basal levels
at day 3 (9.30 ± 1.2) and day 5 (8.68 ± 1.86) postopera-
tive. With respect to TKR surgery, the total leukocyte
concentration decreased from baseline (7.16 ± 1.59) to 5
minutes reperfusion (6.08 ± 0.49). Total leukocytes then
increased following 15 minutes reperfusion (6.84 ± 0.68)
and peaked at day 1 postoperative (10.38 ± 3.01). By day
3 (10.04 ± 1.27) and day 5 (8.58 ± 2.15) postoperative
the total leukocyte concentrations decreased toward
basal levels.
CD62L (L-selectin) expression
The results are expressed as mean fluorescent intensity
(MFI) and represent the changes in the CD62L cell sur-
face expression of neutrophils and monocytes following
THR and TKR surgery (Figures 2a+b). Following THR
surgery significant changes were seen in neutrophil
CD62L cell surface expression (p = 0.003, as determined
by ANOVA) (Figure 2a). This expression decreased
from baseline (30.27 ± 6.42), during day 1 (28.01 ± 6.57)
and day 3 (20.50 ± 4.06) postoperatively. CD62L cell
surface expression increased above basal levels at day 5
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of these data showed significant differences between
baseline vs day 3 postoperative (p = 0.017).
A significant decrease was seen in neutrophil CD62L
cell surface expression following TKR surgery (p =
0.001, as determined by the Friedman test) (Figure 2a).
This expression decreased from baseline (32.79 ± 4.49),
during 5 minutes (27.93 ± 2.23) and 15 minutes (25.95
± 1.76) reperfusion, with levels being at their lowest at
day 1 postoperative (18.72 ± 9.39). CD62L expression
on neutrophils gradually increased toward basal levels at
day 3 (26.09 ± 3.58) and day 5 (31.71 ± 2.98) postopera-
tively. Upon further analysis the Wilcoxon test showed
significant differences between baseline vs 5 and 15 min-
utes reperfusion, day 1 and day 3 postoperatively (p =
<0.05).
Although no significant changes were observed in the
monocyte CD62L cell surface expression following THR
surgery (p = 0.213, as determined by ANOVA) (Figure
2b), a trend of decreasing CD62L cell surface expression
from baseline (33.86 ± 2.74) to day 1 postoperative was
seen (26.45 ± 2.04). At day 3 (30.28 ± 8.17) and day 5
(31.12 ± 3.37) postoperative the CD62L cell surface
expression on monocytes increased back toward basal
levels.
Monocytes displayed a trend of decreasing CD62L cell
surface expression from baseline (27.77 ± 4.75), during
5 (25.09 ± 4.11) and 15 (24.70 ± 3.51) minutes reperfu-
sion following TKR surgery (Figure 2b). This expression
increased towards or above basal levels at day 1 (27.81 ±
3.93), day 3 (26.03 ± 10.21) and day 5 (33.67 ± 8.76)
postoperative, although no overall significant changes
were observed (p = 0.281, as determined by ANOVA).
CD11b expression
Following THR surgery significant changes were seen in
neutrophil CD11b cell surface expression (p = <0.05)
(Figure 3a). Levels increased from baseline (24.49 ±
2.07), during day 1 (31.99 ± 5.67) and peaked at day 3
(34.95 ± 2.39) (p = 0.027) postoperatively, then
decreased toward basal levels at day 5 postoperative
(27.72 ± 5.82).
A significant increase was seen in neutrophil CD11b
cell surface expression following TKR surgery (p =
<0.05), (Figure 3a). This expression increased from base-
line (27.00 ± 5.85), during 5 (28.66 ± 5.81) and 15
(32.80 ± 4.58) minutes reperfusion, peaking at day 1
postoperative (36.19 ± 3.68). CD11b expression on neu-
trophils gradually decreased toward basal levels at day 3
(34.61 ± 6.01) postoperatively, and was less than that of
basal values at day 5 (23.70 ± 3.15) postoperative. Upon
f u r t h e ra n a l y s i sb yp a i r w i s ec omparison testing signifi-
cant differences between baseline vs 15 minutes reperfu-
sion (p = 0.022) was observed.
Although no significant changes were observed in the
monocyte CD11b cell surface expression following THR
surgery, a trend of increasing CD11b expression from
baseline (46.90 ± 13.72) to day 1 postoperative was seen
(54.01 ± 5.81). At day 3 (51.55 ± 7.2) postoperative the
Figure 1 Effect of THR and TKR surgery on total leukocyte concentration. The points represent mean ± SD. p = <0.05 for THR and TKR, as
determined by ANOVA and the Friedman tests respectively. p = 0.05 baseline vs day 1 postoperative THR, as determined by pairwise
comparison testing; p = <0.05 baseline vs 5 minutes reperfusion, day 1 and day 3 postoperative TKR, as determined by the Wilcoxon test. (*, p <
0.05 compared to baseline).
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toward basal levels, and at day 5 (37.5 ± 5.09) post-
operatively the CD11b expression was lower than that
of basal levels (Figure 3b).
Monocytes displayed a significant increase in CD11b
cell surface expression (p = 0.004) from baseline (34.82
± 6.45), during 5 (39.20 ± 7.05) minutes, 15 (43.11 ±
7.54) minutes reperfusion, and peaking at day 1 post-
operatively (47.62 ± 8.31) following TKR surgery.
CD11b expression decreased toward basal levels at day
3 (43.36 ± 10.21) and day 5 (34.85 ± 5.33) postoperative
(Figure 3b).
The CD11b cell surface expression on monocytes was
consistently higher than that seen in neutrophils follow-
ing both THR and TKR surgery, which may be due to
the fact that monocytes are larger that neutrophils and
express more CD11b on their surfaces.
Intracellular H2O2 production
Following THR surgery significant changes were seen in
neutrophil intracellular H2O2 production (p = 0.035)
Figure 2 Effect of THR and TKR surgery on CD62L cell surface expression of neutrophils (A) and monocytes (B). A, the points represent
mean ± SD. p = <0.001 for neutrophils following THR and TKR surgery, as determined by ANOVA and the Friedman tests respectively. Baseline
vs day 3 postoperative following THR p = 0.017, as determined by pairwise comparisons. p = <0.05 baseline vs 5 and 15 minutes reperfusion,
day 1 and day 3 postoperatively following TKR (Wilcoxon test). (* = p < 0.05 compared to baseline). B, the points represent mean ± SD.
p = >0.05 for monocytes following THR and TKR surgery.
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peaking at day 1 (572 ± 236) postoperatively. Intracellu-
lar H2O2 production decreased toward basal levels at
day 3 (559 ± 128) and day 5 postoperative (405 ± 104).
A trend of increasing neutrophil intracellular H2O2
production from baseline (365 ± 90), during 5 minutes
(398 ± 44), 15 minutes (441 ± 34) reperfusion, day 1 (471
± 131) and peaking at day 3 (496 ± 165) postoperatively
was observed following TKR surgery (Figure 4a). The
intracellular H2O2 production in neutrophils decreased
below basal levels at day 5 postoperatively (344 ± 255).
These differences in neutrophil intracellular H2O2 pro-
duction following TKR surgery were not significant.
Although no significant changes were observed in the
monocyte intracellular H2O2 production following THR
surgery (Figure 4b), a trend of increasing intracellular
H2O2 production from baseline (257 ± 118) to day 1
postoperative was seen (497 ± 219). At day 3 (457 ±
177) and day 5 (283 ± 34) postoperative H2O2 levels in
monocytes decreased toward basal levels.
Figure 3 Effect of THR and TKR surgery on CD11b cell surface expression of neutrophils (A) and monocytes (B). A, the points represent
mean ± SD. p = <0.05 for neutrophils following THR and TKR surgery, as determined by ANOVA. Baseline vs day 3 postoperative following THR
(p = 0.027, as determined by pairwise comparisons). Baseline vs 15 minutes reperfusion, following TKR (p = 0.022, as determined by pairwise
comparisons). (*, p < 0.05 compared to baseline). B, the points represent mean ± SD. p = 0.004 for monocytes following TKR, as determined by
ANOVA.
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lular H2O2 production (p = 0.002) from baseline (239 ±
56), during 5 (296 ± 55) and 15 (320 ± 44) minutes
reperfusion, and peaking at day 1 postoperatively (446 ±
75) (p = 0.011) following TKR surgery (Figure 4b). The
intracellular H2O2 production of monocytes then
decreased toward basal levels at day 3 (365 ± 135) and
day 5 (236 ± 103) postoperatively.
Leukocyte elastase
Although no significant changes were observed in the
elastase concentration following THR surgery (Figure 5),
a trend of increasing elastase concentration from base-
line (20.16 ± 5.46), during day 1 postoperative (57.94 ±
26.73), peaking at day 3 postoperative (71.52 ± 46.34)
was seen. At day 5 (43.16 ± 18.19) postoperative the
elastase concentration following THR surgery decreased
toward basal levels. Following TKR surgery significant
changes were seen leukocyte elastase concentrations (p
= 0.003) (Figure 5). Leukocyte elastase concentrations
increased from baseline (19.20 ± 4.52), during 5 (26.81
± 9.01) and 15 (34.44 ± 24.52) (p < 0.05) minutes reper-
fusion, and peaked at day 1 (77.00 ± 27.80) (p < 0.05)
Figure 4 Effect of THR and TKR surgery on intracellular H2O2 production of neutrophils (A) and monocytes (B). A, the points represent
mean ± SD. p = 0.035, as determined by ANOVA following THR surgery. B, the points represent mean ± SD. p = 0.002, as determined by
ANOVA following TKR surgery. Baseline vs day 1 postoperative following TKR (p = 0.011, as determined by pairwise comparisons) (*, p < 0.05
compared to baseline).
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(42.98 ± 18.05) and day 5 (30.88 ± 12.08) postopera-
tively, although still remained at a higher level to those
of basal values (p < 0.05 for day 3).
Effect of THR and TKR orthopaedic surgery on endothelial
markers
vWF
The results are expressed as ng/ml and represent the
changes in vWF concentration following THR and TKR
surgery (Figure 6). This parameter was measured as a
marker of endothelial activation. Although no significant
changes were observed in the vWF concentration fol-
lowing THR surgery (p = 0.08, as determined by
ANOVA), a trend of increasing vWF concentration
from baseline (0.93 ± 0.46), during day 1 (1.95 ± 0.89)
and peaking at day 3 postoperative was seen (2.56 ±
1.22). At day 5 (2.46 ± 0.55) postoperative the vWF con-
centration decreased marginally and remained two fold
higher to that of basal values.
With regards to TKR surgery (Figure 6) significant
changes were observed in vWF concentrations (p =
<0.001, as determined by ANOVA). vWF concentrations
Figure 5 Effect of THR and TKR surgery on elastase concentration. The points represent mean ± SD, p = 0.003 for TKR surgery, as
determined by the Friedman test. p = <0.05 baseline vs 15 minutes reperfusion, day 1 and day 3 postoperative, as determined by the Wilcoxon
test. (*, p < 0.05 compared to baseline).
Figure 6 Effect of THR and TKR surgery on vWF concentration. The points represent mean ± SD, p = <0.001 TKR surgery, as determined by
ANOVA. Baseline vs day 3 postoperative for TKR surgery (p = <0.05), as determined by pairwise comparison tests. (*, p < 0.05 compared to baseline).
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0.88) and 15 (1.50 ± 0.87) minutes reperfusion, at day 1
(2.16 ± 0.64), and peaking at day 3 (3.98 ± 0.86) postopera-
tively. vWF concentration decreased at day 5 (2.64 ± 0.70)
postoperatively, although remained at a higher level to
those of basal values (2 fold). Upon further analysis pair-
wise comparison testing showed significant differences
between baseline vs day 3 postoperatively (p < 0.05).
sICAM-1
The results are expressed as ng/ml and represent the
changes in sICAM-1 concentration following THR and
TKR surgery (Figure 7). This parameter was measured
as marker of endothelial activation. Following THR sur-
gery significant changes were seen in sICAM-1 concen-
trations (p = 0.032, as determined by ANOVA). sICAM-
1 concentration increased from baseline (186.90 ±
29.12), during day 1 (240.17 ± 54.67), day 3 (275.71 ±
46.24), and peaked at day 5 (330.72 ± 87.44) postopera-
tively. Although no significant changes were observed in
the sICAM-1 concentration following TKR surgery (p =
0.068, as determined by the Friedman test), a trend of
increasing sICAM-1 concentration from baseline (180.28
± 57.45), 5 (207.11 ± 51.25) and 15 (214.00 ± 82.88)
minutes reperfusion, day 1 (221.20 ± 55.70), day 3
(263.94 ± 94.78) and day 5 (307.85 ± 49.52) postopera-
tive was seen (Figure 7).
Discussion
Results from the study demonstrated evidence of
increased leukocytosis following THR and TKR surgery.
Specifically, THR surgery resulted in increased total leu-
kocyte counts, peaking at day 1 postoperatively, and
although this appeared to be decreasing at day 5 post-
operatively it still remained higher to those of basal
values (pre-operative). Similar patterns were observed
following TKR surgery. The results obtained during this
study complement previous studies which provided evi-
dence of leukocytosis following various surgeries such as
total hip replacement surgery, and provide further evi-
dence of increased leukocytosis up to day 5 post THR
and TKR surgery [2,3]. It may therefore be appreciated
that following long-bone surgical intervention there is a
systemic response resulting in leukocytosis. These
changes possibly take effect due to increased bone mar-
row turnover which has resulted from THR and TKR
surgery procedures, postoperative wound and tissue
repair, or probably due to a combination of these contri-
buting factors.
During this clinical study there was a significant effect
on neutrophil CD62L expression following both THR
and TKR surgery. Similar trends were also observed in
monocytes following both THR and TKR surgery,
although these did not reach statistical significance.
CD62L cell surface expression decreased from baseline
(preoperatively), up to day 3 (THR) and up to day 1
(TKR). This was in agreement with Fassbender et al,
(1999) who also reported a decrease in leukocyte CD62L
expression following THR [17]. Interpretation of the
results from the present study suggests that there was
increased shedding of CD62L from the cell surface of
Figure 7 Effect of THR and TKR surgery on sICAM-1 concentration. The points represent mean ± SD, p = 0.032 for THR surgery, as
determined by ANOVA.
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d e n c ei n d i c a t e st h a tC D 6 2 Lm a yp l a yar o l ed u r i n gt h e
early rolling stages of the leukocyte adhesion cascade
and provides further evidence that monocytes follow a
similar pattern post-surgery, which may facilitate leuko-
cyte adhesion to the vascular endothelium during the
acute inflammatory response following surgery.
Another element of the current investigations was to
ascertain whether THR and TKR surgery resulted in
changes in the cell surface expression of the CD11b
adhesion molecule. There was a significant effect of
THR and TKR surgery on the CD11b cell surface
expression of neutrophils and monocytes (TKR surgery
only). Results demonstrated an increase in CD11b
expression from baseline (preoperative) up to day 3
postoperatively (THR) and up to day 1 (TKR) for both
neutrophils and monocytes. This expression in mono-
cytes was consistently higher than that seen in neutro-
phils. The up-regulation of CD11b was evident in both
the phagocytic leukocytes (neutrophils and monocytes),
and suggests that CD11b on these cells may be binding
to counter-receptors, such as ICAM-1 present on the
surface of vascular endothelium. This would occur as
part of the inflammatory response post-orthopaedic sur-
gery, where increased ICAM-1 may be due to elevated
production due to endothelial activation. In agreement
with others who demonstrated an increased neutrophil
CD11b expression following upper limb surgery [6], this
present study complements their findings and provides
further evidence of monocytic involvement (represented
by increased CD11b expression) during the acute phase
response following both THR and TKR surgery.
Increased leukocyte adhesion to the vascular endothe-
lium during an inflammatory response is associated with
cell activation [18,19]. During the present study leuko-
cyte activation following THR and TKR was assessed by
measuring the intracellular production of H2O2 by neu-
trophils and monocytes. Both these cells displayed a sig-
nificant increase in the intracellular production of H2O2,
from baseline (preoperatively) up to day 1 postopera-
tively for neutrophils and monocytes following THR and
TKR respectively. These findings are in accord with
CD11b results which also suggested that neutrophils
and monocytes were activated over a similar time per-
iod. Neutrophils displayed increased intracellular pro-
duction of H2O2 compared to monocytes, suggesting
that neutrophils may be more efficient in performing
the respiratory burst to that of monocytes during an
acute phase response post surgery.
In addition to changes to H2O2 production, during
leukocyte activation it can be appreciated that further
bioactive material, such as superoxide and elastase are
released extracellularly [20,21]. Therefore to support the
evidence of increased leukocyte activation following
THR and TKR surgery measurement of leukocyte elas-
tase was performed. A significant increase in the leuko-
cyte elastase levels were displayed from baseline
(preoperatively) up to day 1 post-surgery following TKR,
with levels decreasing at day 3 and 5 postoperatively.
Evidence of increased leukocyte elastase has also been
reported using a human modelo ft o u r n i q u e t - i n d u c e d
forearm ischaemia-reperfusion injury, where elastase
levels increased from baseline, during 10 minutes
ischaemia and up to 15 minutes reperfusion [5].
Collectively, the actions of the degradative substances
H2O2 and elastase may potentially cause damage to host
tissue following major orthopaedic surgery. Measurements
of the intracellular production of H2O2 and elastase by
phagocytic leukocytes may therefore provide a useful mar-
ker that could be applied to monitoring post-operative
complications and clinical outcome after TKR or THR.
Endothelial activation following THR and TKR surgery
was assessed via measurement of vWF and sICAM-1
concentrations, which are established markers of
endothelial activation [22-24]. During the present study,
significant changes in vWF concentration following TKR
surgery were evident, with an increase from baseline up
to day 3 postoperative and similarly for THR surgery
although not significant. A significant increase in sICAM-
1 was also demonstrated from baseline (preoperative) up
to day 5 postoperative following THR surgery, with a
similar trend being observed following TKR surgery. Data
obtained from this study suggest that there is an
increased liberation of vWF from the storage organelles
of the vascular endothelium following surgery, and that
ICAM-1 may be up-regulated and is being shed into the
blood. The up-regulation of ICAM-1 fits with the
increased levels of CD11b expression by leukocytes,
which may facilitate leukocyte-endothelial cell interac-
tions following orthopaedic surgery. In comparison to a
study performed by Klimiuk et al (2002), who demon-
strated increased serum concentrations of sICAM-1 and
sE-selectin in patients with rheumatoid arthritis, the cur-
rent study provides further evidence of increased sICAM-
1 levels following major orthopaedic surgery [24]. Fedi et
al, (1999) measured vWF levels before and during THR
and TKR surgeries yet found no significant changes, how-
ever their study did not investigate postoperatively the
effects of surgery on vWF levels [25]. The present study
provides further evidence that significant changes to vWF
levels do occur following TKR, especially after 3 days,
and suggests that this parameter may provide useful mar-
ker for monitoring endothelial activation following joint
replacement surgery.
During THR, no tourniquet is used and the operated
area is always well vascularised, and clamping and dia-
thermia is only used to stop surgical bleeding. TKR sur-
gical procedures involve the application of a tourniquet,
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form their work. Despite this difference, both tourniquet
(TKR) and non-tourniquet (THR) applied orthopaedic
surgery produced similar changes in leukocyte and
endothelial markers.
It is proposed that changes in the measured biological
parameters during this study may not be due to a single
factor, but due to a number of factors that may result
following surgery such as: tissue damage, wound repair,
introduction of foreign material (e.g. prosthesis) and
ischaemia-reperfusion injury during THR replacement
surgery.
Changes in the leukocyte and endothelial markers are
indicative of increased inflammatory reactions after
orthopaedic trauma. It is therefore proposed that leuko-
cyte and endothelial markers such as CD62L, CD11b,
H2O2, elastase, vWF and sICAM-1, may provide an
alternative method for monitoring an acute inflamma-
tory response postoperatively, in comparison to the con-
ventional method of measuring CRP. Infections,
including those that are subclinical, are a complication
after orthopaedic surgery and CRP has limitations in its
use. Other markers that could monitor or predict infec-
tions are lacking. Therefore the leukocyte and endothe-
lial markers described in the present study could be
useful in this regard.
Conclusion
It appears that changes in the leukocyte and endothelial
m a r k e r sf o l l o w i n gT H Ra n dT K Rs u r g e r yf o l l o w e da
similar pattern. In general most of the markers mea-
sured during these studies peaked between days 1-3
postoperatively, when the most noticeable changes
occurred. Changes in CD62L, CD11b, H2O2,e l a s t a s e ,
vWF and sICAM-1 levels may therefore have clinical
implications for understanding the development of
inflammatory responses post surgery.
Acknowledgements
The authors are indebted to the participants who kindly agreed to take part
in this study. They are also very grateful to the orthopaedic surgeons
involved with the study for providing the blood samples prior to and
following surgery. Thanks go to Professor J. Richardson, RJAH Orthopeadic
Hospital, Oswestry for helpful discussions. Finally, the authors thankfully
acknowledge the Institute of Biomedical Science (IBMS) and the North Wales
Research Committee (NWRC) for their financial support.
Author details
1Department of Biological Sciences, University of Chester, UK.
2Haematology
Department, North Wales (Central) NHS Trust, UK.
3Haematology
Department, North (West) Wales NHS Trust, UK.
4Rheumatology Department,
North Wales (Central) NHS Trust, UK.
5Orthopaedics Department, North Wales
(Central) NHS Trust. UK.
6Leopold Muller Arthritis Research Centre, RJAH
Orthopaedic Hospital, Medical School, Keele University, UK.
Authors’ contributions
SFH carried out the isolation of leukocyte sub-populations, assessment of
leukocyte adhesion, assessment of total leukocyte counts, assessment of
leukocyte activation and the immunoassays. BDH performed assessment of
the inflammatory response. SSB participated in the design and collection of
the blood sampling procedure. DRE and KMM advised on the clinical
implications. SFH and JFM supervised the study, participated in its design
and coordination and drafted the manuscript. All authors read and approved
the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 4 June 2009
Accepted: 19 January 2010 Published: 19 January 2010
References
1. Wiik H: Inflammatory response following abdominal surgery and its
modulation by recombinant human granulocyte colony-stimulating
factor (rhG-CSF, filgrastim). Acta Universitatis Ouluensis, Medica 2002, ISSN
1796-2234.
2. Høgevold HE, Lyberg T, Reikerås O: Changes in leukocyte subpopulations
following total hip replacement surgery. Effects of high doses of
corticosteroids. Scand J Clin Lab Inves 1999, 51(5):443-51.
3. Spark JI, Scott DJ: Role of the neutrophil in the development of systemic
inflammatory response syndrome and sepsis following abdominal aortic
surgery. Br J Surg 2001, , 12: 1583-1589.
4. Zimmerman BJ, Granger DN: Mechanisms of reperfusion injury. Am J Med
Sci 1994, 307:284-292.
5. Hughes SF, Cotter MJ, Evans S-A, Jones KP, Adams RA: The role of
leukocytes in damage to the vascular endothelium during ischaemia-
reperfusion injury. (Br) Journal of Biomedical Science 2006, 63(4):166-170.
6. Lan W, Harmon D, Wang JH, Ghori K, Shorten G, Redmond P: The effect of
lidocaine on in vitro neutrophil and endothelial adhesion molecule
expression induced by plasma obtained during tourniquet-induced
ischaemia and reperfusion. Eur J Anaesthesiol 2004, , 11: 892-897.
7. Shahid M, Tauseef M, Sharma KK, Fahim M: Brief femoral artery ischaemia
provides protection against myocardial ischaemia/reperfusion injury in
rats: the possible mechanisms. Experimental Physiology 2008, 93(8):954-
968.
8. Higuchi T, Yamauchi-Takihara K, Matsumiya G, Fukushima N, Ichikawa H,
Kuratani T, Maehata Y, Sawa Y: Granulocyte colony-stimulating factor
prevents reperfusion injury after heart preservation. The Annals of
thoracic surgery 2008, , 4: 1367-73.
9. Engler RL: Free radical and granulocyte-mediated injury during
myocardial ischemia and reperfusion. Am J Cardiol 1989, 63:19E-23E.
10. Aldemir O, Celebi H, Cevik C, Duzgun E: The effects of propofol or
halothane on free radical production after tourniquet induced
ischaemia-reperfusion injury during knee arthroplasty. Acta Anaesthesiol
Scand 2001, 5:1221-1225.
11. Tsui JC, Baker DM, Biecker E, Shaw S, Dashwood MR: Altered endothelin-1
levels in acute lower limb ischemia and reperfusion. Angiology 2004,
55(5):533-539.
12. Arieli D, Nahmany G, Casap N, Ad-El D, Samuni Y: , The effect of a
nitroxide antioxidant on ischemia-reperfusion injury in the rat in vivo
hind limb model. Free Radical Research 2008, 114-23.
13. Sandovici M, Henning RH, van Goor H, Helfrich W, de Zeeuw D,
Deelman LE: Systemic gene therapy with interleukin-13 attenuates renal
ischemia-reperfusion injury. Kidney International 2008, 73(12):1363-1373.
14. Lennie SE, Lowe GDO, Barbenel JC: Filterability of white blood cell
subpopulations, separated by an improved method. Clin Hemorheol 1987,
7:811-816.
15. Bass DA, Parce JW, Dechatelet LR, Szedja P, Seeds MC, Thomas M: Flow
cytometric studies of oxidative product formation by neutrophils: a
graded response to membrane stimulation. The Journal of Immunology
1983, 1910-1917.
16. Brower MS, Harpel PC: Alpha-1-antitrypsin-human leukocytes elastase
complexes in blood quantification by an enzyme-linked differential
antibody immunosorbent assay and comparison with alpha-2-plasmin
inhibitor-plasmin complexes. Blood 1983, 842-849.
17. Fassbender K, Kaptur S, Becker P, Gröschel J, Schmidt R, Hennerici M:
Inverse association between endogenous glucocorticoid secretion and
L-selectin (CD62L) expression in trauma patients. Life Sci 1999,
65(23):2471-2480.
Hughes et al. Journal of Inflammation 2010, 7:2
http://www.journal-inflammation.com/content/7/1/2
Page 11 of 1218. Ley K, Brook A: Inflammation - The leukocyte adhesion cascade. Nature
Reviews 2000, 467-479.
19. Mousa SA: Cell adhesion molecules: potential therapeutic diagnostic
implications. Molecular biotechnology 2008, , 1: 33-40.
20. Inauen W, Granger DN, Meininger CJ, Schelling ME, Granger HJ, Kvietys PR:
Anoxia-reoxygenation-induced, neutrophil-mediated endothelial cell
injury: role of elastase. American Journal of Physiology 1990, H925-31.
21. Lowe GD: Circulating inflammatory markers and risks of cardiovascular
and non-cardiovascular disease. J Thromb Haemost 2005, 3(8):1618-27.
22. Blann AD, McCollum CN: Von Willebrand factor, endothelial cell damage
and atherosclerosis. Eur J Vasc Surg 1994, 8:10-15.
23. Wei M, Kuukasjarvi P, Laurikka J, Kaukinen S, Iisalo P, Laine S, Tarkka M:
Soluble adhesion molecules and myocardial injury during coronary
artery bypass grafting. World Journal of Surgery 2003, 140-144.
24. Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik JP, Cylwik B, Skowronski J,
Chwiecko J: Soluble adhesion molecules (ICAM-1, VCAM-1, and E-
selectin) and vascular endothelial growth factor (VEGF) in patients with
distinct variants of rheumatoid synovitis. Annals of Rheumatic Diseases
2002, 61:804-809.
25. Fedi S, Gori AM, Falciani M, Cellai AP, Aglietti P, Baldini A, Vena LM,
Prisco D, Abbate R, Gensini GF: Procedure-dependence and tissue factor-
independence of hypercoagulability during orthopaedic surgery. Thromb
Haemost 1999, , 6: 874-8.
doi:10.1186/1476-9255-7-2
Cite this article as: Hughes et al.: Total hip and knee replacement
surgery results in changes in leukocyte and endothelial markers. Journal
of Inflammation 2010 7:2.
Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Hughes et al. Journal of Inflammation 2010, 7:2
http://www.journal-inflammation.com/content/7/1/2
Page 12 of 12